Menu Search
Equities

Olympus Corp

7733:TYO

Olympus Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,256.00
  • Today's Change65.00 / 2.97%
  • Shares traded3.88m
  • 1 Year change-7.64%
  • Beta0.8670
Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
Select bar for recommendation details.
Recommendations18-Apr-24
Buy3
Outperform7
Hold5
Underperform0
Sell0

Share price forecast in JPY

The 12 analysts offering 12 month price targets for Olympus Corp have a median target of 2,450.00, with a high estimate of 2,850.00 and a low estimate of 2,000.00. The median estimate represents a 8.60% increase from the last price of 2,256.00.
High26.3%2,850.00
Med8.6%2,450.00
Low-11.3%2,000.00

Dividends in JPY

In 2023, Olympus Corp reported a dividend of 16.00 JPY, which represents a 14.29% increase over last year. The 15 analysts covering the company expect dividends of 17.67 JPY for the upcoming fiscal year, an increase of 10.42%.
Div growth (TTM)14.29%
More ▼

Earnings history & estimates in JPY

On Feb 14, 2024, Olympus Corp reported 3rd quarter 2024 earnings of 17.78 per share.
The next earnings announcement is expected on May 10, 2024.
Average growth rate+284.57%
Olympus Corp reported annual 2023 earnings of 113.22 per share on May 12, 2023.
Average growth rate+327.04%
More ▼

Revenue history & estimates in JPY

Olympus Corporation had 3rd quarter 2024 revenues of 239.07m. This bettered the 235.48m consensus of the 6 analysts covering the company. This was 11.68% above the prior year's 3rd quarter results.
Average growth rate+2.03%
Olympus Corporation had revenues for the full year 2023 of 881.92m. This was 1.50% above the prior year's results.
Average growth rate+3.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.